PET/MRI scans to map brain tumor activity
Part of Cancer clinical trials.
This study uses special PET and MRI scans to map the activity and oxygen levels of brain tumors (gliomas). The results help doctors plan treatment that is more tailored to each patient.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a brain tumor and are already participating in a related study.
- You can undergo PET and MRI scans without needing anesthesia (a mild anti-anxiety pill is okay).
- You are generally fit and can care for yourself (ECOG score of 2 or better).
- You are expected to live more than 12 weeks.
- Your kidney function is adequate (not severely reduced).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
This study tests a special imaging method to look at brain tumors before surgery. It uses a tracer that may help doctors see tumors more clearly.
This study uses MRI scans to find higher-risk areas in certain brain and other solid tumors and help plan radiation treatment. It also looks for changes in tumor “metabolites” (chemicals in the tumor) that may relate to how the tumor behaves.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.